Weikert S - Search Results

1

Efficacy of sunitinib re-exposure after failure of an mTOR inhibitor in patients with metastatic RCC.

Grünwald V, Weikert S, Seidel C, Busch J, Johannsen A, Fenner M, Reuter C, Ganser A, Johannsen M. Grünwald V, et al. Among authors: weikert s. Onkologie. 2011;34(6):310-4. doi: 10.1159/000328575. Epub 2011 May 6. Onkologie. 2011. PMID: 21625184

2

Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies.

Grünwald V, Seidel C, Fenner M, Ganser A, Busch J, Weikert S. Grünwald V, et al. Among authors: weikert s. Br J Cancer. 2011 Nov 22;105(11):1635-9. doi: 10.1038/bjc.2011.389. Epub 2011 Oct 27. Br J Cancer. 2011. PMID: 22033275 Free PMC article. Clinical Trial.

3

Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma.

Busch J, Seidel C, Weikert S, Wolff I, Kempkensteffen C, Weinkauf L, Hinz S, Magheli A, Miller K, Grünwald V. Busch J, et al. Among authors: weikert s. BMC Cancer. 2011 Jul 14;11:295. doi: 10.1186/1471-2407-11-295. BMC Cancer. 2011. PMID: 21756335 Free PMC article.

4

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.

Seidel C, Busch J, Weikert S, Steffens S, Fenner M, Ganser A, Grünwald V. Seidel C, et al. Among authors: weikert s. Eur J Cancer. 2012 May;48(7):1023-30. doi: 10.1016/j.ejca.2012.02.048. Epub 2012 Mar 20. Eur J Cancer. 2012. PMID: 22436979

5

Categories of response to first line vascular endothelial growth factor receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma.

Busch J, Seidel C, Goranova I, Erber B, Peters R, Friedersdorff F, Magheli A, Miller K, Grünwald V, Weikert S. Busch J, et al. Among authors: weikert s. Eur J Cancer. 2014 Feb;50(3):563-9. doi: 10.1016/j.ejca.2013.10.017. Epub 2013 Nov 13. Eur J Cancer. 2014. PMID: 24239449

6

Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy.

Johannsen M, Staehler M, Ohlmann CH, Flörcken A, Schmittel A, Otto T, Bex A, Hein P, Miller K, Weikert S, Grünwald V. Johannsen M, et al. Among authors: weikert s. Ann Oncol. 2011 Mar;22(3):657-663. doi: 10.1093/annonc/mdq437. Epub 2010 Sep 24. Ann Oncol. 2011. PMID: 20870911 Free article.

7

Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC).

Seidel C, Busch J, Weikert S, Steffens S, Bokemeyer C, Grünwald V. Seidel C, et al. Among authors: weikert s. Br J Cancer. 2013 Dec 10;109(12):2998-3004. doi: 10.1038/bjc.2013.662. Epub 2013 Oct 29. Br J Cancer. 2013. PMID: 24169357 Free PMC article.

8

Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors.

Weikert S, Kempkensteffen C, Busch J, Johannsen M, Grünwald V, Zimmermann K, Flörcken A, Westermann J, Weinkauf L, Miller K, Keilholz U. Weikert S, et al. World J Urol. 2013 Aug;31(4):805-9. doi: 10.1007/s00345-011-0676-1. Epub 2011 Apr 22. World J Urol. 2013. PMID: 21512806

9

Sequence therapy in patients with metastatic renal cell carcinoma: comparison of common targeted treatment options following failure of receptor tyrosine kinase inhibitors.

Busch J, Seidel C, Kempkensteffen C, Johannsen M, Wolff I, Hinz S, Magheli A, Miller K, Grünwald V, Weikert S. Busch J, et al. Among authors: weikert s. Eur Urol. 2011 Dec;60(6):1163-70. doi: 10.1016/j.eururo.2011.07.037. Epub 2011 Jul 21. Eur Urol. 2011. PMID: 21802830

10

Retrospective comparison of triple-sequence therapies in metastatic renal cell carcinoma.

Busch J, Seidel C, Erber B, Issever AS, Hinz S, Kempkensteffen C, Magheli A, Miller K, Grünwald V, Weikert S. Busch J, et al. Among authors: weikert s. Eur Urol. 2013 Jul;64(1):62-70. doi: 10.1016/j.eururo.2012.09.004. Epub 2012 Sep 11. Eur Urol. 2013. PMID: 22999519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page